BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36454255)

  • 1. [Thrombotic microangiopathies in surgical intensive care medicine with special consideration of atypical hemolytic uremic syndrome].
    Albrecht S; Kamla CE; Schönermarck U; Wassilowsky D
    Anaesthesiologie; 2023 Jan; 72(1):3-12. PubMed ID: 36454255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.
    Joseph A; Rafat C; Zafrani L; Mariani-Kurkdjian P; Veyradier A; Hertig A; Rondeau E; Mariotte E; Azoulay E
    Crit Care Med; 2018 Sep; 46(9):e904-e911. PubMed ID: 29979220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
    Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
    Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic approach to microangiopathic hemolytic disorders.
    Kottke-Marchant K
    Int J Lab Hematol; 2017 May; 39 Suppl 1():69-75. PubMed ID: 28447417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment of microangiopathic hemolytic anemia].
    Morishita E
    Rinsho Ketsueki; 2015 Jul; 56(7):795-806. PubMed ID: 26251142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
    Laurence J
    Clin Adv Hematol Oncol; 2012 Oct; 10(10 Suppl 17):1-12. PubMed ID: 23187605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in a renal transplant recipient case report.
    Nieto-Rios JF; Zuluaga-Quintero M; Valencia-Maturana JC; Bello-Marquez DC; Aristizabal-Alzate A; Zuluaga-Valencia GA; Serna-Higuita LM; Arias LF
    J Bras Nefrol; 2021; 43(4):591-596. PubMed ID: 33179720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics].
    Rafat C; Coppo P; Fakhouri F; Frémeaux-Bacchi V; Loirat C; Zuber J; Rondeau E
    Rev Med Interne; 2017 Dec; 38(12):817-824. PubMed ID: 28711159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
    Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T
    CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia.
    George JN; Charania RS
    Semin Thromb Hemost; 2013 Mar; 39(2):153-60. PubMed ID: 23390027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Wada H; Matsumoto T; Yamashita Y
    Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of TMA based on Japanese clinical guides].
    Wada H; Hasegawa K; Watanabe M
    Rinsho Ketsueki; 2017; 58(7):849-856. PubMed ID: 28781284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome Microangiopathy in Pregnancy.
    Scully M
    Semin Thromb Hemost; 2016 Oct; 42(7):774-779. PubMed ID: 27648610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where are we with haemolytic uremic syndrome?
    Cavero T; Alonso M
    Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli after pericardiectomy.
    Tome J; Maselli DB; Im R; Amdahl MB; Pfeifle D; Hagen C; Halland M
    Clin J Gastroenterol; 2022 Feb; 15(1):123-127. PubMed ID: 34677733
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.